Pinnacle Wealth Planning Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324 Hold
100
﹤0.01% 2684
2026
Q1
$247 Hold
100
﹤0.01% 2677
2025
Q4
$205 Buy
+100
New +$289 ﹤0.01% 2712
2024
Q4
Sell
-12,075
Closed -$41.2K 438
2024
Q3
$41.2K Sell
12,075
-2,660
-18% -$11.6K 0.01% 530
2024
Q2
$68.8K Buy
+14,735
New +$83.1K 0.01% 494
2021
Q1
Sell
-2,551
Closed -$179K 810
2020
Q4
$179K Buy
+2,551
New +$105K 0.04% 308

Other funds holding EDIT

Pinnacle Wealth Planning Services's EDIT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Editas Medicine (EDIT) position steady in Q2 2026 at 100 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Pinnacle Wealth Planning Services first reported a position in EDIT in Q4 2020 and has held it in 6 quarters since. The position peaked at $179K in Q4 2020. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Pinnacle Wealth Planning Services held 100 shares of Editas Medicine worth $324 as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2684 holding.
  • Pinnacle Wealth Planning Services first reported a position in Editas Medicine in Q4 2020 and has held it in 6 quarters since.
  • Pinnacle Wealth Planning Services's Editas Medicine position peaked at $179K in Q4 2020.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.